Drug Profile
OVI 117
Alternative Names: Derivative of FduMP/5-FU (OVI-117); L-117; L-nucleoside conjugate (OVI-117); OVI-117Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Genencor International; Lipitek International
- Developer OncoVista
- Class Antineoplastics; Drug conjugates; Nucleosides
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer